TPG, a private equity investment firm, completed the investment in Ampersand Capital-backed Confluent Medical, a provider of outsourced design and manufacturing services for the medical device industry. Financial terms were not disclosed. “Confluent’s depth of expertise in Nitinol processing and other complex modalities, differentiated manufacturing capabilities and unique end-to-end integration have positioned the company as a trusted design and manufacturing partner to OEMs for many of the most complex implantable products. With an accomplished management team, robust pipeline, and long track record of product innovation, we believe the company is positioned to build on its market-leading reputation for quality and execution in some of the highest growth medical device end-markets," Kendall Garrison, TPG Capital Partner.